Loading...
•
Jun 30, 2020
Myomo Q2 2020 Earnings Report
Revenue exceeded projections as COVID-19 restrictions eased, and authorization backlog reached a record level, up 50% sequentially.
Key Takeaways
Myomo reported a 2% decrease in revenue compared to Q2 2019, totaling $0.9 million, but exceeded expectations due to strengthened deliveries and increased average selling prices as the U.S. economy began to re-open. The company's authorization backlog increased by 50% sequentially, reaching 120 units.
Revenue was $0.9 million, down 2% year-over-year but exceeded the expected revenue range.
Direct billing revenue increased 329% and represented 50% of total revenue.
Operating expenses were $3.3 million, compared to $3.2 million in Q2 2019.
Backlog was 120 units as of June 30, 2020, a 50% increase compared to March 31, 2020.
Forward Guidance
Myomo expects to deliver a record number of MyoPro’s in the third quarter as it serves its growing backlog, which should result in significantly increased revenue in the months ahead.
Positive Outlook
- Expects to deliver a record number of MyoPro’s in the third quarter.
- Anticipates significantly increased revenue in the months ahead.
- Provided staff with personal protective equipment (PPE) and training on proper and safe procedures.
- Has PPE available for patients during the MyoPro delivery process.
- Continues to experience strong demand for its product line while adding new initiatives such as the recently launched MyoCare™ program.
Challenges Ahead
- If public health and travel restrictions are re-imposed, the Company may require additional capital to fund its operations during the second half of 2021.
- The direct and indirect impact of the novel coronavirus (COVID-19) on our business and operations, including fabrication and delivery, sales, patient consultations, supply chain, manufacturing, insurance reimbursements and employees.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...